Patient guide

Fertility and sex during cancer treatment

Fertility preservation should be raised before treatment starts; a guide to the options, contraception and sexual health during and after treatment

Updated: 28 October 20264 min read12 references
Show content for:

Key points

  • Chemotherapy (especially alkylating drugs), radiotherapy to the pelvis or brain, surgery on the reproductive organs and stem cell transplant can reduce fertility temporarily or permanently [1, 2].
  • The ASCO guideline recommends that all patients be counselled about fertility risks at diagnosis and that fertility preservation be raised before treatment starts [5].
  • The main methods: sperm freezing in men; freezing embryos, eggs or ovarian tissue, and moving the ovaries before radiotherapy in women [5].
  • Survivors who had seen a fertility specialist had less regret, whatever they decided [1].
  • Reduced fertility does not mean pregnancy is impossible; use contraception during treatment and ask about using condoms [1, 3, 4].
  • Sexual problems can be treated: vaginal lubricants and moisturisers, medicines to improve erections and sex counselling are common options [10].

How does cancer treatment affect fertility?

The effect of treatment on fertility depends on the type, dose and length of treatment, the patient's age, the time since treatment, the type and site of the tumour and fertility before the illness [1, 2].

  • Chemotherapy: some drugs, especially alkylating agents, carry a high risk; in women the ovaries may stop producing eggs and oestrogen (premature ovarian insufficiency), and in men the sperm-making cells may be damaged. High doses or combinations of several drugs increase the risk [1, 2].
  • Radiotherapy: radiation to the pelvis can damage the ovaries or testicles; radiation near the womb can change its blood supply, and radiation to the brain may affect the glands that control fertility hormones [1, 2].
  • Surgery: removal of the womb or both ovaries, or pelvic operations such as on the prostate, bladder and rectum, can affect fertility or ejaculation [1, 2].
  • Hormone therapy: can cause ovarian insufficiency in women and lower the sperm count in men [1, 2].
  • Targeted therapy and immunotherapy: their effect on fertility is still being studied; some tyrosine kinase inhibitors may reduce fertility [1, 2].

Premature ovarian insufficiency can bring hot flushes, night sweats, irregular or absent periods, vaginal dryness and lower sex drive, and in the long term it raises the risk of osteoporosis and heart disease [1].

Fertility preservation: before treatment starts

Suggested steps at diagnosis

  1. 1

    1. Raise the subject

    Ask your oncologist how the proposed treatment will affect your fertility and whether there is a lower-risk treatment option. Sometimes you need to start this conversation yourself [1, 2].

  2. 2

    2. Referral to a fertility specialist

    If you would like to have children in the future or are not yet sure, ask for an early referral to a fertility specialist (oncofertility or reproductive endocrinology) [5].

  3. 3

    3. Choosing the right method

    Your care team and the fertility specialist look together at the timing of fertility preservation and the possible effect of any delay in starting treatment [2].

  4. 4

    4. Follow-up after treatment

    If there was no chance to preserve fertility before treatment, or not enough eggs or embryos were stored, fertility preservation methods may also be offered after treatment [5].

Fertility preservation methods
MethodFor whomExplanation
Sperm freezingMen after pubertyThe commonest method; it must be done before treatment. If a semen sample is not possible, extracting sperm from the testicle (TESE) is an option [2, 5].
Embryo freezingWomen after pubertyStimulating the ovaries with medicines, collecting eggs, fertilising them in the laboratory and freezing the embryos [1, 5].
Egg freezingWomen after pubertyCollecting and freezing mature eggs for fertilisation in the future [1, 5].
Ovarian tissue freezingWomen and girls, including the only established method before pubertySurgically removing ovarian tissue and transplanting it back in the future [1, 5].
Moving the ovariesWomen having pelvic radiotherapyMoving the ovaries surgically out of the radiation field [1, 5].
Testicular shieldMen having pelvic radiotherapyA cover to reduce scattered radiation to the testicles [2].
GnRH agonist with chemotherapyWomen with breast cancerNot a replacement for established methods, but it can be offered as an extra method [5, 7].

Freezing testicular tissue in boys before puberty is still experimental and is done only in clinical studies [5].

Sex and contraception during treatment

For patients

What you should know

Sex is usually possible

Most women and men can have sex during treatment, but check with your doctor; you may be advised to avoid it at times when the risk of infection or bleeding is high [3, 4].

Condoms

Some chemotherapy drug may stay in semen or vaginal fluids for a while; for this reason using a condom is sometimes advised to protect your partner [3, 4].

Contraception

Even with reduced fertility, pregnancy can happen, and some treatments harm an unborn baby or cause miscarriage. Ask your doctor which method you need and for how long after treatment [1].

Physical changes

In women, lower oestrogen from chemotherapy, hormone therapy or pelvic radiotherapy can lead to vaginal dryness and pain during sex [3]. In men, chemotherapy may lower sex drive during treatment but usually does not affect erections; pelvic radiotherapy, hormone therapy and pelvic surgery can cause erection problems [4].

Effective treatments

Vaginal lubricants and moisturisers, sometimes low-dose vaginal oestrogen (in some cancers), vaginal dilators after radiotherapy, pelvic floor exercises, medicines that increase blood flow to the penis and penile implants are among the options [3, 4, 10].

Talking helps

Talking with your partner, psychological or sex counselling and support groups help improve intimacy, body image and sexual satisfaction [3, 10].

Pregnancy after cancer

Show detailsHide

For many survivors, pregnancy after treatment is possible. An important example is the POSITIVE study: 516 women aged 42 or younger with early hormone receptor-positive breast cancer paused their hormone therapy after 18 to 30 months to try for a pregnancy. About 3 in every 4 women who were followed became pregnant, and most of them had a baby. Breast cancer did not come back more often within 3 years than in women who had not paused treatment; that is, this short break did not raise the risk, at least in the first few years [9]. Longer follow-up is still needed, and the decision should be made with your oncologist.

For physiciansGuideline summary
For physicians

Guideline summary for physicians

  • ASCO 2025 (fertility preservation): assess and counsel on fertility risks at diagnosis and during survivorship; refer interested or uncertain patients to a fertility specialist; discuss methods before treatment. In men: sperm cryopreservation before treatment and TESE if a semen sample is not possible; warn about a possibly higher risk of genetic damage in sperm collected soon after starting or finishing treatment; prepubertal testicular tissue cryopreservation only in trials. In women: embryo, oocyte and ovarian tissue cryopreservation, ovarian transposition and conservative gynaecological surgery; in vitro maturation of oocytes (IVM) as an emerging method. GnRHa should not replace established methods, but it can be offered as an adjunct in breast cancer and used to suppress menstruation in oncological emergencies. The only established method in prepubertal girls is ovarian tissue cryopreservation [5].
  • Individual patient data meta-analysis of GnRHa in early breast cancer (873 patients, 5 trials): premature ovarian insufficiency 14.1% versus 30.9% (adjusted odds ratio 0.38); pregnancy after treatment 10.3% versus 5.5% (incidence rate ratio 1.83); no significant difference in disease-free or overall survival [7]. The POEMS trial was also done with goserelin alongside chemotherapy [8].
  • ESMO 2020: guideline on fertility preservation and pregnancy after treatment in post-pubertal patients [6].
  • ASCO 2018 (sexual problems): the care team should start the conversation about sexual health; psychosocial or psychosexual counselling should be offered to all patients; treatable medical factors should be addressed first. For vaginal atrophy, lubricants and moisturisers as first choice; low-dose vaginal oestrogen, lidocaine and DHEA in some cases. In men, PDE5 inhibitors and surgery in refractory cases. For vasomotor symptoms: CBT, paced breathing, hypnosis, venlafaxine and gabapentin [10].

When should I call my doctor?

  • Before starting any treatment, if you are thinking about having children in the future; the chance to preserve fertility may be lost once treatment starts [5].
  • If you think you might be pregnant during treatment (a late period or a positive test); some treatments harm an unborn baby [1].
  • Unusual vaginal bleeding (outside your period or heavier than usual) during treatment [11].
  • A temperature of 38 °C or higher during chemotherapy; this is an emergency [12].
  • Pain, burning or unusual discharge from the genitals, or early menopause symptoms that disrupt daily life [1, 3].

Frequently asked questions

If my periods stop during chemotherapy, does it mean I cannot get pregnant?

Not necessarily. Some women with ovarian insufficiency after treatment still ovulate and have irregular or occasional periods; in others the damage is permanent [1]. So contraception is needed during treatment [1].

Does fertility preservation delay cancer treatment?

Your care team and the fertility specialist plan the timing together and discuss the effect of any delay with you [2]. In emergencies where immediate treatment is needed, the options are more limited [5].

Is pregnancy after hormone-positive breast cancer dangerous?

In the POSITIVE study, pausing hormone therapy to become pregnant in selected women did not raise the risk of recurrence in the short term [9]. This decision should be made individually with your oncologist.

Why should we use condoms?

To protect your partner from traces of chemotherapy drug in semen or vaginal fluids, and to prevent pregnancy [3, 4].

References

12 references
Show all references, 6 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Female Fertility and Cancer TreatmentNational Cancer Institute · cancer.gov
    Source Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
  2. 2
    Male Fertility and Cancer TreatmentNational Cancer Institute · cancer.gov
    Source Back to text: 1 2 3 4 5 6 7 8 9 10 11 12
  3. 3
    Sexual Health Issues in Women with CancerNational Cancer Institute · cancer.gov · 2022
    Source Back to text: 1 2 3 4 5 6 7 8
  4. 4
    Sexual Health Issues in Men with CancerNational Cancer Institute · cancer.gov
    Source Back to text: 1 2 3 4 5 6
  5. 5
    Fertility Preservation in People With Cancer: ASCO Guideline UpdateSu HI, Lacchetti C, Letourneau J, Partridge AH, Qamar R, Quinn GP, et al · J Clin Oncol · 2025;43:1488-1515
    Study cardDOIPubMed Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
  6. 6
    Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice GuidelinesLambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al · Ann Oncol · 2020;31:1664-1678
  7. 7
    Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level DataLambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al · J Clin Oncol · 2018;36:1981-1990
    Study cardDOIPubMed Back to text: 1 2
  8. 8
    Goserelin for Ovarian Protection during Breast-Cancer Adjuvant ChemotherapyMoore HCF, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, et al · N Engl J Med · 2015;372:923-932
  9. 9
    Interrupting Endocrine Therapy to Attempt Pregnancy after Breast CancerPartridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, et al · N Engl J Med · 2023;388:1645-1656
    Study cardDOIPubMed Back to text: 1 2
  10. 10
    Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario GuidelineCarter J, Lacchetti C, Andersen BL, Barton DL, Bolte S, Damast S, et al · J Clin Oncol · 2018;36:492-511
    Study cardDOIPubMed Back to text: 1 2 3 4
  11. 11
    Bleeding and Bruising (Thrombocytopenia) and Cancer TreatmentNational Cancer Institute · cancer.gov · 2022
  12. 12
    Infection and Neutropenia during Cancer TreatmentNational Cancer Institute · cancer.gov · 2020

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.